On this World AIDS Day global leaders, WHO, NGOs and citizens join forces to address the importance of tackling the HIV epidemics in order to…
News
Our new oncology patent WO2022180080 was approved and is already available in the WIPO database. The patent protects a new generation of antitumor agents with…
Since the publication of our Reservoir Reducing results by our partners of the Erasmus Medical Center in Nature Communications last year, several new studies by…
It is with great sadness that we have to communicate the death of our dear friend and co-founder of First Health Pharmaceuticals, F. Wouter (Mickey)…
DISCLAIMER: Fraud Recruitment Offers ! Please be aware of a job scam circulating on behalf of First Health Pharmaceuticals B.V. Don’t apply to any…
A study led by First Health Pharmaceuticals B.V. (FHPBV) and the Italian Institute of oncological research and prevention (ISPRO), together with the University of Siena…
Today, the prestigious scientific journal Nature Communications published the article “Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir”.…
World AIDS Day occurring each December 1, helps reminding civil society and governments every year that HIV is still relevant. Its awareness-raising mission includes activities…
First Health Pharmaceuticals has been investigating the activity of its compounds on the replication of various RNA viruses, therefore, no wonder that we have also…
A few days after the coronavirus disease 2019 (CoViD-19) outbreak turned out to be a pandemic, all of a sudden it became necessary to tackle…